Katalyze AI Raises $10.5M Seed for Pharma Agent Platform

July 13, 2026

Fundraise Insider tracks newly funded startups each week and delivers verified B2B leads list of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.

Katalyze AI, based in Mountain View, California, has raised $10.5 million in a seed round to build an agentic AI operating system for pharmaceutical companies. Bonfire Ventures led the financing, with participation from Inovia Capital, Ripple Ventures, Alumni Ventures and angel investors including Gokul Rajaram.

The platform pulls fragmented production data into a single source-grounded record and runs a catalog of domain-trained agents. Led by chief executive Reza Farahani, Katalyze says it is already deployed across 5 of the 20 largest global pharmaceutical companies and has supported the delivery of 10 million medication doses to patients.

The company will use the capital to expand its engineering, scientific and go-to-market teams, grow its catalog of agents and scale deployments with large pharmaceutical firms.

You may also like

35 Sales Email Tips to Crush Your Sales Game

In today’s digital age, email remains one of the most effective tools for reaching out to potential customers and driving sales. However, crafting a successful sales email can be tricky, as you need […]

Recently Funded Startups Are A Great Sales Target. Here’s Why.

The startup industry has been growing at an unprecedented rate in recent years, with billions of dollars being poured into the sector every year. This growth has created an opportunity for businesses to […]

How to Identify Your B2B Target Audience: A Comprehensive Guide

For any business to succeed, it is essential to target the right audience. In B2B marketing, identifying your target audience is even more important, as it helps you focus your efforts and resources […]